{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T02:06:36Z","timestamp":1794362796074,"version":"4.9.0"},"reference-count":25,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2002,4,25]],"date-time":"2002-04-25T00:00:00Z","timestamp":1019692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2002,5]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold> One hundred and twenty\u2010six infants with acute lymphoblastic leukaemia (ALL) were treated on two consecutive protocols, Infant 87 (<jats:italic>n<\/jats:italic>\u2003=\u200340) and Infant 92 (<jats:italic>n<\/jats:italic>\u2003=\u200386), in an attempt to improve the poor prognosis of this disease. Both included intensive induction and consolidation with intrathecal and high\u2010dose systemic therapy for central nervous system (CNS) protection. Intensification therapy was modified and high\u2010dose chemotherapy with bone marrow transplantation in first remission was permitted in Infant 92. Four\u2010year event\u2010free survival was superior in Infant 92 (33%; 95% CI 23\u201344%) compared with Infant 87 (22\u00b75%; 95% CI 12\u201337%) (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b704) and survival at 4\u2003years was also superior, 46% (95% CI \t35\u201357%) c.f. 32\u00b75% (95% CI 20\u201348%) (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b701), largely as a result of a significant reduction in remission deaths. Twelve patients in Infant 92 underwent bone marrow transplantation (BMT) in first remission, but their survival was no better than that of patients receiving chemotherapy. Multivariate analysis of prognostic factors showed the adverse influence of younger age, CNS involvement at diagnosis and a high initial leucocyte count, but not of CD10 expression. Cytogenetic analysis, available in 93% of patients in Infant 92, showed that 67% had chromosomal rearrangements involving 11q23 of which 39% had the translocation t(4;11) (q21;q23). There was no significant difference in event\u2010free survival between cytogenetic subgroups, although no children under 6\u2003months of age with 11q23 abnormalities, other than the t(4;11), survived. In conclusion, infants with lymphoblastic leukaemia remain a high\u2010risk group, but it is unclear whether their adverse prognosis can be attributed to unfavourable cytogenetics alone. The role of high\u2010dose therapy and BMT in first remission remains uncertain.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2002.03442.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:44:12Z","timestamp":1047365052000},"page":"306-314","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987\u20131999"],"prefix":"10.1111","volume":"117","author":[{"given":"J. M.","family":"Chessells","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. J.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. L.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. J.","family":"Vora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Medical Research Council Working Party on Childhood Leukaemia*","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,4,25]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.1.24"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1983.1.5.317"},{"key":"e_1_2_6_4_1","first-page":"1275","article-title":"Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on childhood leukaemia","volume":"8","author":"Chessells J.M.","year":"1994","journal-title":"Leukemia"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.3493163.x"},{"key":"e_1_2_6_6_1","doi-asserted-by":"crossref","unstructured":"Chessells J.M. Harrison C.J. Webb D.K.H. Wheatley K. Hann I.M. Stephens R.F. Harrison G.&Gibson B.E.(2002)Clinical features cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia Working Party.Leukemia (in press).","DOI":"10.1038\/sj.leu.2402468"},{"key":"e_1_2_6_7_1","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1182\/blood.V94.4.1209","article-title":"Prednisolone response is the strongest predictor of treatment ooutcome in infant acute lymphoblastic leukemia","volume":"94","author":"Dordelmann M.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_6_8_1","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1182\/blood.V95.8.2729","article-title":"Treatment outcome in infant acute lymphoblastic leukemia","volume":"95","author":"Ferster A.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199701000-00005"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401093"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401704"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.01801.x"},{"key":"e_1_2_6_13_1","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/sj.leu.2401413","article-title":"Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t(4;11) \u2013 a report of the Children's Cancer Group","volume":"13","author":"Heerema N.A.","year":"1999","journal-title":"Leukemia"},{"key":"e_1_2_6_14_1","first-page":"466a","article-title":"UKALL XI randomised trial stratified CNS treatments and prospective neurophychological assessment in childhood acute lymphoblastic leukaemia (ALL)","volume":"96","author":"Hill F.G.H.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401148"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199805000-00008"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401818"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.1002914.x"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1977.1"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401129"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-911X(199901)32:1<1::AID-MPO2>3.0.CO;2-J"},{"key":"e_1_2_6_22_1","first-page":"952","article-title":"Prognostic factors in the acute lymphoid and myeloid leukemias of infants","volume":"10","author":"Pui C.H.","year":"1996","journal-title":"Leukemia"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.2.445"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12<2285::AID-CNCR10>3.3.CO;2-N"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00677.x"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.6.1714"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03442.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03442.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2002.03442.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T02:38:10Z","timestamp":1697423890000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2002.03442.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4,25]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,5]]}},"alternative-id":["10.1046\/j.1365-2141.2002.03442.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2002.03442.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,4,25]]},"assertion":[{"value":"2002-04-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}